1
|
Penela D, Falasconi G, Carreño JM, Soto-Iglesias D, Fernández-Armenta J, Acosta J, Martí-Almor J, Benito B, Bellido A, Chauca A, Scherer C, Viveros D, Alderete J, Silva E, Ordoñez A, Francisco-Pascual J, Rivas-Gandara N, Meca-Santamaria J, Franco P, De Lucia C, Ali H, Cappato R, Cámara O, Francia P, Berruezo A. A hybrid clinical and electrocardiographic score to predict the origin of outflow tract ventricular arrhythmias. J Interv Card Electrophysiol 2023; 66:1877-1888. [PMID: 36795268 DOI: 10.1007/s10840-023-01507-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/12/2022] [Accepted: 02/04/2023] [Indexed: 02/17/2023]
Abstract
BACKGROUND To predict the outflow tract ventricular arrhythmias (OTVA) site of origin (SOO) before the ablation procedure has important practical implications. The present study sought to prospectively evaluate the accuracy of a clinical and electrocardiographic hybrid algorithm (HA) for the prediction of OTVAs-SOO, and at the same time to develop and to prospectively validate a new score with improved discriminatory capacity. METHODS In this multicenter study, we prospectively enrolled consecutive patients referred for OTVA ablation (N = 202), and we divided them in a derivation sample and a validation cohort. Surface ECGs during OTVA were analyzed to compare previous published ECG-only criteria and to develop a new score. RESULTS In the derivation sample (N = 105), the correct prediction rate of HA and ECG-only criteria ranged from 74 to 89%. R-wave amplitude in V3 was the best ECG parameter for discriminating LVOT origin in V3 precordial transition (V3PT) patients, and was incorporated to the novel weighted hybrid score (WHS). WHS correctly classified 99 (94.2%) patients, presenting 90% sensitivity and 96% specificity (AUC 0.97) in the entire population; WHS mantained a 87% sensitivity and 91% specificity (AUC 0.95) in patients with V3PT subgroup. The high discriminatory capacity was confirmed in the validation sample (N = 97): the WHS exhibited an AUC (0.93), and a WHS ≥ 2 allowed a correct prediction of LVOT origin in 87 (90.0%) cases, yielding a sensitivity of 87% and specificity of 90%; moreover, the V3PT subgroup showed an AUC of 0.92, and a punctuation ≥ 2 predicted an LVOT origin with a sensitivity of 94% and specificity of 78%. CONCLUSIONS The novel hybrid score has proved to accurately anticipate the OTVA's origin, even in those with a V3 precordial transition. A Weighted hybrid score. B Typical examples of the use of the weighted hybrid score. C ROC analysis of WHS and previous ECG criteria for prediction of LVOT origin in the derivation cohort. D ROC analysis of WHS and previous ECG criteria for prediction of LVOT origin in the V3 precordial transition OTVA subgroup.
Collapse
Affiliation(s)
- Diego Penela
- Heart Institute, Teknon Medical Centre, C/ Vilana, 12; 08022, Barcelona, Spain
| | - Giulio Falasconi
- Heart Institute, Teknon Medical Centre, C/ Vilana, 12; 08022, Barcelona, Spain
- University of Barcelona, Campus Clínic, Barcelona, Spain
| | - Jose Miguel Carreño
- Heart Institute, Teknon Medical Centre, C/ Vilana, 12; 08022, Barcelona, Spain
| | - David Soto-Iglesias
- Heart Institute, Teknon Medical Centre, C/ Vilana, 12; 08022, Barcelona, Spain
| | | | - Juan Acosta
- Virgen del Rocío University Hospital, Sevilla, Spain
| | - Julio Martí-Almor
- Heart Institute, Teknon Medical Centre, C/ Vilana, 12; 08022, Barcelona, Spain
| | - Begoña Benito
- Hospital Vall d'Hebron, Barcelona, Spain
- Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Aldo Bellido
- Heart Institute, Teknon Medical Centre, C/ Vilana, 12; 08022, Barcelona, Spain
| | - Alfredo Chauca
- Heart Institute, Teknon Medical Centre, C/ Vilana, 12; 08022, Barcelona, Spain
| | - Claudia Scherer
- Heart Institute, Teknon Medical Centre, C/ Vilana, 12; 08022, Barcelona, Spain
| | - Daniel Viveros
- Heart Institute, Teknon Medical Centre, C/ Vilana, 12; 08022, Barcelona, Spain
- University of Barcelona, Campus Clínic, Barcelona, Spain
| | - Jose Alderete
- Heart Institute, Teknon Medical Centre, C/ Vilana, 12; 08022, Barcelona, Spain
- University of Barcelona, Campus Clínic, Barcelona, Spain
| | | | - Augusto Ordoñez
- Heart Institute, Teknon Medical Centre, C/ Vilana, 12; 08022, Barcelona, Spain
| | | | | | | | - Paula Franco
- Heart Institute, Teknon Medical Centre, C/ Vilana, 12; 08022, Barcelona, Spain
| | | | - Hussam Ali
- IRCCS Multimedica Group, Sesto San Giovanni, Italy
| | | | | | - Pietro Francia
- Cardiology, Department of Clinical and Molecular Medicine, St. Andrea Hospital, Sapienza University, Rome, Italy
| | - Antonio Berruezo
- Heart Institute, Teknon Medical Centre, C/ Vilana, 12; 08022, Barcelona, Spain.
| |
Collapse
|
2
|
Cantalapiedra Romero J, Pijuan-Domenech A, Galian-Gay L, Miranda-Barrios B, Serrano-Sanchez B, Goya-Canino M, Maiz-Elizaran N, Gordon-Ramirez B, Gonzalez-Fernandez V, Francisco-Pascual J, Rodriguez-Silva J, Pascual-Gonzalez G, Rivas-Gandara N, Dos-Subira L, Ferreira-Gonzalez I. Risk of cardiac complications during pregnancy in patients with cardiac devices. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Pregnant women with cardiac devices (pacemaker or defibrillators [ICD]) are increasing in developed countries. Risk stratification in these patients is challenging, since presence of cardiac devices are not considered specifically neither in mWHO nor CARPREG II scales. In addition, the previous evidence is scarce and heterogeneous, based mostly on observational studies published years ago.
Purpose
To describe the intrinsic risk for cardiovascular complications of pregnant women with cardiac devices.
Methods
We designed a prospective study including all pregnancies under follow-up in our Heart Disease and Pregnancy Unit between January 2013 and December 2020, selecting those patients with an intracardiac device at the time of pregnancy. Following institutional review board approval, data were collected from medical records in order to classify the patients according to the type of heart disease and the mWHO scale. CARPREG II scale was calculated retrospectively from 2014 to 2018 and prospectively afterwards. All cardiological complications were identified during each pregnancy and puerperium, defined as the appearance of heart failure, arrhythmias or thrombotic complications.
Since our patients were classified in mWHO groups 2 or 2–3, we compared the incidence of complications between our cohort of patients with devices and the rest of the pregnancies of mWHO 2–3 patients without devices. We also included in the analysis patients with an unspecified mWHO. A mWHO IV patient was excluded from analysis.
Results
A total of 323 pregnancies were identified, of which 15 were in patients with devices (4.6%) and 135 in mWHO 2–3 patients without devices (41.8%). There were 9 pregnancies in 6 pacemaker carriers and 6 in 6 ICD carriers. The mean age was 34.3 years. None of them had other cardiovascular risk factors. A total of 2 cardiac complications were identified: one patient in the pacemaker group and another in the ICD group presented with a lead thrombosis at 25 and 30 weeks respectively. In both patients, anticoagulation with weight-adjusted enoxaparin was started. In the other hand, in the mWHO 2–3 patients without devices we identified 2 complications in the form of heart failure episodes: one during third trimester and another in puerperium.
When comparing our device patient group (n=14) with the mWHO 2–3 patients without devices (n=135), we observed a statistically significant higher incidence of complications in the device group (14.3% vs 1.5%, p=0.002).
Conclusions
Pregnant women with cardiac devices have a higher risk of complications than pregnant women with a similar risk profile according to the mWHO scale, mainly in the form of lead thrombosis.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- J Cantalapiedra Romero
- University Hospital Vall d'Hebron, Arrhythmias and Electrophysiology Department , Barcelona , Spain
| | - A Pijuan-Domenech
- University Hospital Vall d'Hebron, Integrated Vall d'Hebron-Sant Pau Adult Congenital Heart Disease Unit , Barcelona , Spain
| | - L Galian-Gay
- University Hospital Vall d'Hebron, Cardiology Department , Barcelona , Spain
| | - B Miranda-Barrios
- University Hospital Vall d'Hebron, Integrated Vall d'Hebron-Sant Pau Adult Congenital Heart Disease Unit , Barcelona , Spain
| | - B Serrano-Sanchez
- University Hospital Vall d'Hebron, Obstetrics and Ginecology Department , Barcelona , Spain
| | - M Goya-Canino
- University Hospital Vall d'Hebron, Obstetrics and Ginecology Department , Barcelona , Spain
| | - N Maiz-Elizaran
- University Hospital Vall d'Hebron, Obstetrics and Ginecology Department , Barcelona , Spain
| | - B Gordon-Ramirez
- University Hospital Vall d'Hebron, Integrated Vall d'Hebron-Sant Pau Adult Congenital Heart Disease Unit , Barcelona , Spain
| | - V Gonzalez-Fernandez
- University Hospital Vall d'Hebron, Integrated Vall d'Hebron-Sant Pau Adult Congenital Heart Disease Unit , Barcelona , Spain
| | - J Francisco-Pascual
- University Hospital Vall d'Hebron, Arrhythmias and Electrophysiology Department , Barcelona , Spain
| | - J Rodriguez-Silva
- University Hospital Vall d'Hebron, Arrhythmias and Electrophysiology Department , Barcelona , Spain
| | - G Pascual-Gonzalez
- University Hospital Vall d'Hebron, Arrhythmias and Electrophysiology Department , Barcelona , Spain
| | - N Rivas-Gandara
- University Hospital Vall d'Hebron, Arrhythmias and Electrophysiology Department , Barcelona , Spain
| | - L Dos-Subira
- University Hospital Vall d'Hebron, Integrated Vall d'Hebron-Sant Pau Adult Congenital Heart Disease Unit , Barcelona , Spain
| | - I Ferreira-Gonzalez
- University Hospital Vall d'Hebron, Cardiology Department , Barcelona , Spain
| |
Collapse
|
3
|
Peinado R, Cano O, Rivas-Gandara N, Alvarez-Ortega C, Garcia-Orta R, Diaz-Infante E, Segura-De La Cal T, Lopez-Ledesma B, Cantalapiedra-Romero J, Macias R, Rueda J, Dos-Subira L, Gallego-Garcia De Vinuesa P, Gonzalez-Garcia AE, Oliver-Ruiz JM. Spanish registry of cardiac resynchronization therapy in adults with congenital heart disease (RETRACCA): clinical outcomes at one year follow-up. Europace 2022. [DOI: 10.1093/europace/euac053.548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Spanish Society of Cardiology
Background
There are limited data about the impact of cardiac resynchronization therapy (CRT) in adults with congenital heart disease (CHD) with conflicting results in patients (P) with systemic right ventricle (SRV).
Objectives
We analyzed the one-year outcomes of adults with CHD implanted with CRT and the impact of CRT in P with SRV as compared with systemic left ventricle (SLV).
Methods
Data were analyzed from the Spanish Registry of CRT in adults with CHD (RETRACCA). This is an observational, ambispective (66 % retrospective), multicenter Registry, including 74 adults with CHD implanted with a CRT device from 6 Spanish centers from 2007 to 2021. Ventricular function was assessed by echocardiography and graded on a four-point ordinal scale. Response to CRT was defined as an improvement in NYHA functional class and/or systemic ventricular ejection fraction by at least one category. In addition to changes in functional class and ventricular function, other outcomes analyzed included mortality, heart transplantation and CRT-related complications.
Results
68 P completed one year of follow-up. Table 1 shows the baseline characteristics of the P prior to CRT. The two main indications for CRT were depressed systolic function of the systemic ventricle with more than 40 % ventricular pacing (69 %) and severely depressed systolic function of systemic ventricle, NYHA FC II-IV and QRS > 150 (18 %). Sixty percent of P received a CRT-ICD, whereas 40 % received a CRT-pacemaker. The approach for CRT system implantation was transvenous in 70 % of the patients, mixed in 21 % and fully epicardial in 9 %. Overall, 43 out of 68 patients (75 %) responded to CRT either by improvement of NYHA FC (56 %) and/or systemic ventricular function (41 %). Compared with baseline, CRT was associated with significant improvement in NYHA FC (p<0.001; figure 1), QRS duration (169±31 vs 150±29; p=0.005), and systemic ventricle systolic function (severe or moderate 80 % vs 58 %; p=0.04). Percentage of responders was similar among patients with a SLV (73 %) and with SRV (81 %; p=0.51). Only pre-implant NYHA FC III-IV was predictive of a positive response in the univariate analysis (OR 3.82; 95 % CI 1.03-14.18). Seven complications occurred at implant (10 %). During the follow-up, there were 8 complications in 7 P: 2 P had heart transplantation, 3 P required hospital admission for decompensation of heart failure, 2 P presented pocket infections and 1 lead malfunction. No differences in complication rates were observed between the systemic LV and systemic RV subgroups.
Conclusions
In this series, at one-year follow-up, CRT resulted in improvement in functional class and/or systemic ventricular function in 75 % of P with adult CHD. The percentages of responders and complications were similar among patients with SLV or SRV.
Collapse
Affiliation(s)
- R Peinado
- University Hospital La Paz, Madrid, Spain
| | - O Cano
- Hospital Universitario y Politecnico La Fe, Valencia, Spain
| | | | | | - R Garcia-Orta
- University Hospital Virgen de las Nieves, Granada, Spain
| | - E Diaz-Infante
- Hospital Universitario Virgen de la Macarena, Sevilla, Spain
| | | | | | | | - R Macias
- University Hospital Virgen de las Nieves, Granada, Spain
| | - J Rueda
- Hospital Universitario y Politecnico La Fe, Valencia, Spain
| | - L Dos-Subira
- University Hospital Vall d’Hebron, Barcelona, Spain
| | | | | | | |
Collapse
|
4
|
Roca-Luque I, Francisco-Pasqual J, Oristrell G, Rodríguez-García J, Santos-Ortega A, Martin-Sanchez G, Rivas-Gandara N, Perez-Rodon J, Ferreira-Gonzalez I, García-Dorado D, Moya-Mitjans A. Flecainide Versus Procainamide in Electrophysiological Study in Patients With Syncope and Wide QRS Duration. JACC Clin Electrophysiol 2019; 5:212-219. [PMID: 30784693 DOI: 10.1016/j.jacep.2018.09.015] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2018] [Revised: 09/07/2018] [Accepted: 09/20/2018] [Indexed: 12/14/2022]
|
5
|
Roca-Luque I, Oristrell G, Francisco-Pasqual J, Rodríguez-García J, Santos-Ortega A, Martin-Sanchez G, Rivas-Gandara N, Perez-Rodon J, Ferreira-Gonzalez I, García-Dorado D, Moya-Mitjans A. Predictors of positive electrophysiological study in patients with syncope and bundle branch block: PR interval and type of conduction disturbance. Clin Cardiol 2018; 41:1537-1542. [PMID: 30251426 DOI: 10.1002/clc.23079] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/16/2018] [Revised: 08/22/2018] [Accepted: 09/20/2018] [Indexed: 01/14/2023] Open
Abstract
BACKGROUND Electrophysiological study (EPS) is indicated in patients with syncope and bundle branch block (BBB). Data about predictors of positive EPS in these patients is scarce. OBJECTIVE To assess clinical and electrocardiographic (ECG) predictors of positive EPS in patients with syncope and BBB. METHODS Observational single-center study that included all consecutive patients with syncope and BBB that underwent EPS from January 2011 to June 2017. Results of EPS were considered positive according to current ESC syncope guidelines. RESULTS During study period, 271 patients were included (64.9% male, age: 73.9 ± 12.2 years, number of syncopal episodes: 2.4 ± 2.5, LVEF: 56.1 ± 9.9%). Type of BBB: RBBB + LAFB/LPFB in 39.8%, isolated LBBB in 38.7% and isolated RBBB in 18.5% of the patients. Duration of QRS and PR interval were 141.9 ± 16.7 and 182.8 ± 52.2 milliseconds. EPS was positive in 41.7% of the patients. In multivariate analysis, conduction disturbance pattern and long PR interval (OR 8.6; 2.9-25; P < 0.0001) were predictors of positive EPS. Conduction disturbance patterns related with positive EPS were: BBB different than isolated RBBB (OR 15.2; 2.2-23.4; P = 0.005), LBBB or RBBB+long PR + left fascicular block (OR 4.5; 1.06-20.01; P < 0.042), and RBBB+left fascicular block compared with LBBB (OR 4.8; 1.2-16.7; P = 0.025). Clinical factors and syncope characteristics were not related with EPS result. CONCLUSIONS Diagnostic yield of EPS in patients with syncope and BBB is moderate (41%). Type of conduction disturbance pattern and PR interval are associated with the electrophysiological (EP) test result. Patients with LBBB or bifascicular block have the highest rate of positive EP test. Long PR interval increases the proportion of positive EPS in all conduction disturbance patterns.
Collapse
Affiliation(s)
- Ivo Roca-Luque
- Arrhythmia Unit. Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - Gerard Oristrell
- Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | | | | | - Alba Santos-Ortega
- Arrhythmia Unit. Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - Gabriel Martin-Sanchez
- Arrhythmia Unit. Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - Nuria Rivas-Gandara
- Arrhythmia Unit. Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - Jordi Perez-Rodon
- Arrhythmia Unit. Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - Ignacio Ferreira-Gonzalez
- Cardiovascular epidemiology Unit. Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | | | - Angel Moya-Mitjans
- Arrhythmia Unit. Cardiology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| |
Collapse
|
6
|
Pérez-Rodon J, Galve E, Pérez-Bocanegra C, Soriano-Sánchez T, Recio-Iglesias J, Domingo-Baldrich E, Alzola-Guevara M, Ferreira-González I, Marsal JR, Ribera-Solé A, Gutierrez García-Moreno L, Cruz-Carlos LM, Rivas-Gandara N, Roca-Luque I, Francisco-Pascual J, Evangelista-Masip A, Moya-Mitjans À, García-Dorado D. A risk score to predict the absence of left ventricular reverse remodeling: Implications for the timing of ICD implantation in primary prevention. J Cardiol 2018; 71:505-512. [PMID: 29183646 DOI: 10.1016/j.jjcc.2017.10.019] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/23/2017] [Revised: 10/24/2017] [Accepted: 10/30/2017] [Indexed: 10/18/2022]
|
7
|
Santos-Ortega A, Perez-Rodon J, Rivas-Gandara N, Roca-Luque I, Francisco-Pascual J, Martin-Sanchez G, Acosta-Velez JG, Oristrell-Santamaria G, Alepuz C, Galve-Basilio E, Garcia-Dorado D, Moya-Mitjans A. P478Early repolarization pattern in patients with structural heart disease: can it really predict sudden cardiac death? Europace 2017. [DOI: 10.1093/ehjci/eux141.201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
8
|
Pérez-Rodon J, Doiny D, Miranda B, Rivas-Gandara N, Roca-Luque I, Francisco-Pascual J, Lidón RM, García-Dorado D, Moya Mitjans A. Life-threatening and life-saving inappropriate implantable cardioverter defibrillator shocks. Clin Case Rep 2017; 5:521-525. [PMID: 28396781 PMCID: PMC5378847 DOI: 10.1002/ccr3.893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2016] [Revised: 01/18/2017] [Accepted: 02/13/2017] [Indexed: 11/22/2022] Open
Abstract
An implantable cardioverter defibrillator (ICD) lead dislodgement into the right atrium is a dangerous situation, particularly in patients in atrial fibrillation because atrial fibrillation can be sensed as ventricular fibrillation and true ventricular fibrillation induced with an inappropriate shock. In the presence of shocks, ICD interrogation should be performed as soon as possible.
Collapse
Affiliation(s)
- Jordi Pérez-Rodon
- Department of Cardiology Arrhythmia Unit Hospital Universitari Vall d'Hebrón Universitat Autònoma de Barcelona Edifici Annexos, planta 9, Passeig Vall d'Hebrón, 119-129 08035 Barcelona Spain
| | - David Doiny
- Department of Cardiology Arrhythmia Unit Hospital Universitari Vall d'Hebrón Universitat Autònoma de Barcelona Edifici Annexos, planta 9, Passeig Vall d'Hebrón, 119-129 08035 Barcelona Spain
| | - Berta Miranda
- Department of Cardiology Hospital Universitari Vall d'Hebrón Universitat Autònoma de Barcelona Edifici Annexos, planta 9, Passeig Vall d'Hebrón, 119-129 08035 Barcelona Spain
| | - Nuria Rivas-Gandara
- Department of Cardiology Arrhythmia Unit Hospital Universitari Vall d'Hebrón Universitat Autònoma de Barcelona Edifici Annexos, planta 9, Passeig Vall d'Hebrón, 119-129 08035 Barcelona Spain
| | - Ivo Roca-Luque
- Department of Cardiology Arrhythmia Unit Hospital Universitari Vall d'Hebrón Universitat Autònoma de Barcelona Edifici Annexos, planta 9, Passeig Vall d'Hebrón, 119-129 08035 Barcelona Spain
| | - Jaume Francisco-Pascual
- Department of Cardiology Arrhythmia Unit Hospital Universitari Vall d'Hebrón Universitat Autònoma de Barcelona Edifici Annexos, planta 9, Passeig Vall d'Hebrón, 119-129 08035 Barcelona Spain
| | - Rosa Maria Lidón
- Department of Cardiology Hospital Universitari Vall d'Hebrón Universitat Autònoma de Barcelona Edifici Annexos, planta 9, Passeig Vall d'Hebrón, 119-129 08035 Barcelona Spain
| | - David García-Dorado
- Department of Cardiology Hospital Universitari Vall d'Hebrón Universitat Autònoma de Barcelona Edifici Annexos, planta 9, Passeig Vall d'Hebrón, 119-129 08035 Barcelona Spain
| | - Angel Moya Mitjans
- Department of Cardiology Arrhythmia Unit Hospital Universitari Vall d'Hebrón Universitat Autònoma de Barcelona Edifici Annexos, planta 9, Passeig Vall d'Hebrón, 119-129 08035 Barcelona Spain
| |
Collapse
|
9
|
Pérez-Rodon J, Galve E, Pérez-Bocanegra C, Soriano-Sánchez T, Recio-Iglesias J, Domingo-Baldrich E, Alzola-Guevara M, Ferreira-Gonzalez I, Marsal JR, Ribera-Solé A, García-Moreno LG, Cruz-Carlos LM, Rivas-Gandara N, Roca-Luque I, Francisco-Pascual J, Evangelista-Masip A, Moya-Mitjans À, Garcia-Dorado D. A Risk Score to Predict the Absence of Left Ventricular Reverse Remodelling: Implications for the Timing of ICD Implantation in Primary Prevention. Eur Cardiol 2017; 12:99. [DOI: 10.15420/ecr.2017:23:8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|